Alternatives
Alternatives to Mixed Salts of a Single-Entity Amphetamine Product 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsule
There are 2 alternatives to this medicine in the catalogue: the same active ingredient (Amphetamine and Dextroamphetamine), strength (12.5 mg/12.5 mg/12.5 mg/12.5 mg) and dosage form (extended-release capsule) from 2 other makers or registers. The table compares packs, storage, lead time, documents and availability.
Side by side
The first row is the medicine you came from.
| Medicine | Manufacturer | Register | Packs | Storage | Lead time | Documents | Availability |
|---|---|---|---|---|---|---|---|
| Mixed Salts of a Single-Entity Amphetamine Product 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleThis pageOral | SpecGx | US FDA | 100 capsules | Store at room temperature, 20°C to 25°C (68°F to 77°F). Excursions permitted between 15°C to 30°C (59°F to 86°F). | On request | — | Available on request |
| Amphetamine and Dextroamphetamine 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleOral | — | US FDA | 100 capsules, 100 capsules | Store at 20º to 25ºC (68º to 77ºF). | On request | — | Available on request |
| Mydayis 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleOral | Takeda Pharmaceuticals | US FDA | 100 capsules | Store at room temperature, 20ºC to 25ºC (68ºF to 77ºF). Excursions permitted between 15ºC to 30ºC (59ºF to 86ºF). | On request | — | Available on request |
Alternatives are listed for sourcing. Whether one medicine can replace another is the prescriber's decision, under the rules of the destination country.
For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Back to Mixed Salts of a Single-Entity Amphetamine Product 12.5 mg/12.5 mg/12.5 mg/12.5 mg extended-release capsuleNot sure which maker to choose?
Request a quote for the medicine and we will propose the options that fit your country's import rules and timelines.